Prevalence of diabetes mellitus in pancreatic cancer compared to common cancers

Gaurav Aggarwal, Pratima Kamada, Suresh T Chari

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Objective: In pancreatic cancer (PaC), the prevalence of diabetes mellitus (DM), especially new-onset DM (≤36 months of PaC diagnosis), is high. To determine if this observation is unique to PaC, we compared the prevalence and characteristics of DM in lung, breast, prostate, and colorectal cancers with PaC and noncancer controls. METHODS: We retrospectively reviewed the medical records of 500 consecutive patients with cancer (100 each with lung, breast, prostate, and colorectal cancers and PaC) and 100 noncancer controls. RESULTS: Patients with PaC (mean age ± SD, 71.6 ± 9.4 years; 53% men) had a significantly (P < 0.0001) higher prevalence of DM (68%) compared to age-matched patients with lung (mean age ± SD, 71.6 ± 9.4 years; 59% men; and 19.6% DM), breast (mean age ± SD, 71.6 ± 9.6 years; 100% women; and 19.4% DM), prostate (mean age ± SD, 71.3 ± 9.4 years; 100% men; and 14.8% DM), and colorectal cancer (mean age ± SD, 71.6 ± 9.5 years; 56% men; and 20.7% DM), and noncancer controls (mean age ± SD, 70.7 ± 9.2 years; 57% men; and 23.5% DM). Among the patients with PaC, 40% developed DM in the 36 months preceding the diagnosis of PaC compared with 3.3% to 5.7% in the other groups (P < 0.0001). CONCLUSIONS: Whereas the prevalence of DM in PaC is very high, DM prevalence in other common cancers is no different from that in noncancer controls. In particular, new-onset DM is a phenomenon that is unique to PaC.

Original languageEnglish (US)
Pages (from-to)198-201
Number of pages4
JournalPancreas
Volume42
Issue number2
DOIs
StatePublished - Mar 2013

Fingerprint

Pancreatic Neoplasms
Diabetes Mellitus
Neoplasms
Colorectal Neoplasms
Lung Neoplasms
Prostatic Neoplasms
Breast Neoplasms
Medical Records
Prostate
Breast

Keywords

  • diabetes mellitus
  • pancreatic cancer
  • screening

ASJC Scopus subject areas

  • Hepatology
  • Internal Medicine
  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Prevalence of diabetes mellitus in pancreatic cancer compared to common cancers. / Aggarwal, Gaurav; Kamada, Pratima; Chari, Suresh T.

In: Pancreas, Vol. 42, No. 2, 03.2013, p. 198-201.

Research output: Contribution to journalArticle

Aggarwal, Gaurav ; Kamada, Pratima ; Chari, Suresh T. / Prevalence of diabetes mellitus in pancreatic cancer compared to common cancers. In: Pancreas. 2013 ; Vol. 42, No. 2. pp. 198-201.
@article{d09d49568f974bf6a05bc8a126e5a438,
title = "Prevalence of diabetes mellitus in pancreatic cancer compared to common cancers",
abstract = "Objective: In pancreatic cancer (PaC), the prevalence of diabetes mellitus (DM), especially new-onset DM (≤36 months of PaC diagnosis), is high. To determine if this observation is unique to PaC, we compared the prevalence and characteristics of DM in lung, breast, prostate, and colorectal cancers with PaC and noncancer controls. METHODS: We retrospectively reviewed the medical records of 500 consecutive patients with cancer (100 each with lung, breast, prostate, and colorectal cancers and PaC) and 100 noncancer controls. RESULTS: Patients with PaC (mean age ± SD, 71.6 ± 9.4 years; 53{\%} men) had a significantly (P < 0.0001) higher prevalence of DM (68{\%}) compared to age-matched patients with lung (mean age ± SD, 71.6 ± 9.4 years; 59{\%} men; and 19.6{\%} DM), breast (mean age ± SD, 71.6 ± 9.6 years; 100{\%} women; and 19.4{\%} DM), prostate (mean age ± SD, 71.3 ± 9.4 years; 100{\%} men; and 14.8{\%} DM), and colorectal cancer (mean age ± SD, 71.6 ± 9.5 years; 56{\%} men; and 20.7{\%} DM), and noncancer controls (mean age ± SD, 70.7 ± 9.2 years; 57{\%} men; and 23.5{\%} DM). Among the patients with PaC, 40{\%} developed DM in the 36 months preceding the diagnosis of PaC compared with 3.3{\%} to 5.7{\%} in the other groups (P < 0.0001). CONCLUSIONS: Whereas the prevalence of DM in PaC is very high, DM prevalence in other common cancers is no different from that in noncancer controls. In particular, new-onset DM is a phenomenon that is unique to PaC.",
keywords = "diabetes mellitus, pancreatic cancer, screening",
author = "Gaurav Aggarwal and Pratima Kamada and Chari, {Suresh T}",
year = "2013",
month = "3",
doi = "10.1097/MPA.0b013e3182592c96",
language = "English (US)",
volume = "42",
pages = "198--201",
journal = "Pancreas",
issn = "0885-3177",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Prevalence of diabetes mellitus in pancreatic cancer compared to common cancers

AU - Aggarwal, Gaurav

AU - Kamada, Pratima

AU - Chari, Suresh T

PY - 2013/3

Y1 - 2013/3

N2 - Objective: In pancreatic cancer (PaC), the prevalence of diabetes mellitus (DM), especially new-onset DM (≤36 months of PaC diagnosis), is high. To determine if this observation is unique to PaC, we compared the prevalence and characteristics of DM in lung, breast, prostate, and colorectal cancers with PaC and noncancer controls. METHODS: We retrospectively reviewed the medical records of 500 consecutive patients with cancer (100 each with lung, breast, prostate, and colorectal cancers and PaC) and 100 noncancer controls. RESULTS: Patients with PaC (mean age ± SD, 71.6 ± 9.4 years; 53% men) had a significantly (P < 0.0001) higher prevalence of DM (68%) compared to age-matched patients with lung (mean age ± SD, 71.6 ± 9.4 years; 59% men; and 19.6% DM), breast (mean age ± SD, 71.6 ± 9.6 years; 100% women; and 19.4% DM), prostate (mean age ± SD, 71.3 ± 9.4 years; 100% men; and 14.8% DM), and colorectal cancer (mean age ± SD, 71.6 ± 9.5 years; 56% men; and 20.7% DM), and noncancer controls (mean age ± SD, 70.7 ± 9.2 years; 57% men; and 23.5% DM). Among the patients with PaC, 40% developed DM in the 36 months preceding the diagnosis of PaC compared with 3.3% to 5.7% in the other groups (P < 0.0001). CONCLUSIONS: Whereas the prevalence of DM in PaC is very high, DM prevalence in other common cancers is no different from that in noncancer controls. In particular, new-onset DM is a phenomenon that is unique to PaC.

AB - Objective: In pancreatic cancer (PaC), the prevalence of diabetes mellitus (DM), especially new-onset DM (≤36 months of PaC diagnosis), is high. To determine if this observation is unique to PaC, we compared the prevalence and characteristics of DM in lung, breast, prostate, and colorectal cancers with PaC and noncancer controls. METHODS: We retrospectively reviewed the medical records of 500 consecutive patients with cancer (100 each with lung, breast, prostate, and colorectal cancers and PaC) and 100 noncancer controls. RESULTS: Patients with PaC (mean age ± SD, 71.6 ± 9.4 years; 53% men) had a significantly (P < 0.0001) higher prevalence of DM (68%) compared to age-matched patients with lung (mean age ± SD, 71.6 ± 9.4 years; 59% men; and 19.6% DM), breast (mean age ± SD, 71.6 ± 9.6 years; 100% women; and 19.4% DM), prostate (mean age ± SD, 71.3 ± 9.4 years; 100% men; and 14.8% DM), and colorectal cancer (mean age ± SD, 71.6 ± 9.5 years; 56% men; and 20.7% DM), and noncancer controls (mean age ± SD, 70.7 ± 9.2 years; 57% men; and 23.5% DM). Among the patients with PaC, 40% developed DM in the 36 months preceding the diagnosis of PaC compared with 3.3% to 5.7% in the other groups (P < 0.0001). CONCLUSIONS: Whereas the prevalence of DM in PaC is very high, DM prevalence in other common cancers is no different from that in noncancer controls. In particular, new-onset DM is a phenomenon that is unique to PaC.

KW - diabetes mellitus

KW - pancreatic cancer

KW - screening

UR - http://www.scopus.com/inward/record.url?scp=84874114984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874114984&partnerID=8YFLogxK

U2 - 10.1097/MPA.0b013e3182592c96

DO - 10.1097/MPA.0b013e3182592c96

M3 - Article

C2 - 23000893

AN - SCOPUS:84874114984

VL - 42

SP - 198

EP - 201

JO - Pancreas

JF - Pancreas

SN - 0885-3177

IS - 2

ER -